The in vivo study revealed that melatonin suppressed the expressions of YAP and PD-L1 in tumor tissues, and administration of melatonin decreased infiltrations of TAM and MDSC while increasing CD8+ and CD4+ T cells. This evidence concerns the gene CD274 and neoplasm.